Q1 2021 Holdings
Filed 2021-05-17 | 20 holdings | $169.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | COM | 230031106 | $113.8M | 2,731,410 | 67.2% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $31.7M | 1,258,243 | 18.7% |
| ALX Oncology Holdings Inc.(ALXO) | COM | 00166B105 | $23.6M | 320,000 | 13.9% |
| Gemini Therapeutics, Inc. | COM | 36870G105 | $33.0K | 2,435,125 | 0.0% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $27.3K | 875,001 | 0.0% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $18.6K | 664,142 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $14.0K | 451,522 | 0.0% |
| Hims & Hers Health, Inc.(HIMS) | COM CL A | 433000106 | $14.0K | 1,056,922 | 0.0% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $13.8K | 400,000 | 0.0% |
| Population Health Investment Co., Inc. | UNIT | G71716123 | $9.6K | 960,000 | 0.0% |
| Olink Holding AB | SPONSORED ADS | 680710100 | $7.2K | 200,000 | 0.0% |
| FS Development Corp. II | COM CL A | 30318F100 | $6.0K | 602,500 | 0.0% |
| Lucira Health, Inc. | COM | 54948U105 | $5.9K | 485,000 | 0.0% |
| Research Alliance Corp. II | COM CL A | 760873109 | $5.1K | 500,000 | 0.0% |
| Bctg Acquisition Corp. | COM | 05492W103 | $4.4K | 400,000 | 0.0% |
| LifeSci Acquisition II Corp. | COM | 53229E103 | $4.1K | 400,000 | 0.0% |
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | $3.7K | 350,000 | 0.0% |
| Helix Acquisition Corp. | COM CL A | G4444C102 | $2.6K | 250,000 | 0.0% |
| Consonance-Hfw Acquisition Corp. | UNIT | 0G244M129 | $976 | 100,000 | 0.0% |
| Immunovant, Inc.(IMVT) | COM | 45258J102 | $802 | 50,000 | 0.0% |